361 related articles for article (PubMed ID: 24239634)
1. Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.
Chahal PS; Schulze E; Tran R; Montes J; Kamen AA
J Virol Methods; 2014 Feb; 196():163-73. PubMed ID: 24239634
[TBL] [Abstract][Full Text] [Related]
2. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
3. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
4. Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities.
Moço PD; Xu X; Silva CAT; Kamen AA
Biotechnol J; 2023 Sep; 18(9):e2300051. PubMed ID: 37337925
[TBL] [Abstract][Full Text] [Related]
5. High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions.
Coplan L; Zhang Z; Ragone N; Reeves J; Rodriguez A; Shevade A; Bak H; Tustian AD
Biotechnol Prog; 2024; 40(3):e3445. PubMed ID: 38450973
[TBL] [Abstract][Full Text] [Related]
6. AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for in vitro and in vivo applications.
Huang X; Hartley AV; Yin Y; Herskowitz JH; Lah JJ; Ressler KJ
J Virol Methods; 2013 Nov; 193(2):270-7. PubMed ID: 23791963
[TBL] [Abstract][Full Text] [Related]
7. Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing.
Vandenberghe LH; Xiao R; Lock M; Lin J; Korn M; Wilson JM
Hum Gene Ther; 2010 Oct; 21(10):1251-7. PubMed ID: 20649475
[TBL] [Abstract][Full Text] [Related]
8. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System.
Adamson-Small L; Potter M; Byrne BJ; Clément N
Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600
[TBL] [Abstract][Full Text] [Related]
9. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.
Lock M; Alvira M; Vandenberghe LH; Samanta A; Toelen J; Debyser Z; Wilson JM
Hum Gene Ther; 2010 Oct; 21(10):1259-71. PubMed ID: 20497038
[TBL] [Abstract][Full Text] [Related]
10. Production of recombinant adeno-associated vectors using two bioreactor configurations at different scales.
Negrete A; Kotin RM
J Virol Methods; 2007 Nov; 145(2):155-61. PubMed ID: 17606302
[TBL] [Abstract][Full Text] [Related]
11. A versatile adeno-associated virus vector producer cell line method for scalable vector production of different serotypes.
Yuan Z; Qiao C; Hu P; Li J; Xiao X
Hum Gene Ther; 2011 May; 22(5):613-24. PubMed ID: 21186998
[TBL] [Abstract][Full Text] [Related]
12. Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
Powers AD; Piras BA; Clark RK; Lockey TD; Meagher MM
Hum Gene Ther Methods; 2016 Jun; 27(3):112-21. PubMed ID: 27229773
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.
Robert MA; Chahal PS; Audy A; Kamen A; Gilbert R; Gaillet B
Biotechnol J; 2017 Mar; 12(3):. PubMed ID: 28177193
[TBL] [Abstract][Full Text] [Related]
15. Scalable recombinant adeno-associated virus production using recombinant herpes simplex virus type 1 coinfection of suspension-adapted mammalian cells.
Thomas DL; Wang L; Niamke J; Liu J; Kang W; Scotti MM; Ye GJ; Veres G; Knop DR
Hum Gene Ther; 2009 Aug; 20(8):861-70. PubMed ID: 19419276
[TBL] [Abstract][Full Text] [Related]
16. AAV2/8 vectors purified from culture medium with a simple and rapid protocol transduce murine liver, muscle, and retina efficiently.
Doria M; Ferrara A; Auricchio A
Hum Gene Ther Methods; 2013 Dec; 24(6):392-8. PubMed ID: 24116943
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing antibodies to candidate gene therapy vectors (adeno-associated vector serotypes) in domestic cats.
Li P; Boenzli E; Hofmann-Lehmann R; Helfer-Hungerbuehler AK
PLoS One; 2019; 14(3):e0212811. PubMed ID: 30897117
[TBL] [Abstract][Full Text] [Related]
18. Continuous Collection of Adeno-Associated Virus from Producer Cell Medium Significantly Increases Total Viral Yield.
Benskey MJ; Sandoval IM; Manfredsson FP
Hum Gene Ther Methods; 2016 Feb; 27(1):32-45. PubMed ID: 26863210
[TBL] [Abstract][Full Text] [Related]
19. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.
Rutledge EA; Halbert CL; Russell DW
J Virol; 1998 Jan; 72(1):309-19. PubMed ID: 9420229
[TBL] [Abstract][Full Text] [Related]
20. Multimodal Production of Adeno-Associated Virus.
Sandoval IM; Kuhn NM; Manfredsson FP
Methods Mol Biol; 2019; 1937():101-124. PubMed ID: 30706392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
